STOCK-BASED COMPENSTION PLANS (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Assumptions for Black-Scholes Option Pricing Model |
The fair value assumptions used to determine the fair value of ESPP rights were estimated on the grant dates using the Black-Scholes option-pricing model with the following assumptions: | | | | | | | | | | | | | Fiscal Year Ended March 31, | Fiscal Year Ended March 31, | Fiscal Year Ended March 31, | | 2026 | 2025 | 2024 | | Expected term (years) | 0.5 | 0.5 | 0.5 | | Expected volatility | 60.0% - 69.0% | 67.6 - 76.0% | 61.9 - 77.6% | | Risk-free interest rate | 3.66% - 4.30% | 4.4 - 5.4% | 5.39 - 5.39% | | Expected dividend yield | — | % | — | % | —% |
| | | | | | | | | | | | | | | | | | | Fiscal Year Ended March 31, | | 2026 | | 2025 | | 2024 | | Expected term (years) | 6.00 | | 5.21 | | 5.26 | | Expected volatility | 69.79 | % | | 70.38 | % | | 73.71 | % | | Risk-free interest rate | 4.07 | % | | 4.54 | % | | 4.21 | % | | Expected dividend yield | — | % | | — | % | | — | % |
|
| Schedule of Stock Option Activity |
The following is a summary of stock option activity for the fiscal year ended March 31, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Number Options Outstanding | | Weighted- Average Exercise Price | | Weighted-Average Remaining Contractual Life (Years) | | Aggregate Intrinsic Value (in millions) | Outstanding as of March 31, 2025 | 457,107 | | | 47.46 | | | 4.73 | | $ | 0.8 | | | Granted | 1,250 | | | 25.20 | | | | | | | Exercised | (8,000) | | | 9.44 | | | | | | | Cancelled or forfeited | (10,034) | | | 25.84 | | | | | | | Expired | (8,990) | | | 151.46 | | | | | Outstanding as of March 31, 2026 | 431,333 | | | $ | 46.43 | | | 4.59 | | $ | — | | Vested and expected to vest as of March 31, 2026 | 429,512 | | | $ | 46.51 | | | 4.57 | | $ | — | | Exercisable as of March 31, 2026 | 389,816 | | | $ | 48.19 | | | 4.28 | | $ | — | |
|
| Schedule of Restricted Stock Units |
The following table summarizes the activity related to the Company’s RSUs for Fiscal Year Ended March 31, 2026: | | | | | | | | | | | | | Number of RSUs | | Weighted Average Grant Date Fair Value | Unvested and outstanding as of March 31, 2025 | 851,259 | | | $ | 30.70 | | | Granted | 672,354 | | | $ | 18.80 | | | Released | (325,914) | | | $ | 31.31 | | | Forfeited | (229,041) | | | $ | 24.68 | | Unvested and outstanding as of March 31, 2026 | 968,658 | | | $ | 23.67 | |
|
| Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity |
The following table summarizes the weighted average grant-date fair value of RSUs and total fair value of vested RSUs for the periods presented: | | | | | | | | | | | | | | | | | | | Fiscal Year Ended March 31, | | 2026 | | 2025 | | 2024 | | Weighted average grant-date fair value of RSUs | $ | 18.80 | | | $ | 30.00 | | | $ | 23.20 | | | Total fair value of released RSUs (in millions) | $ | 5.6 | | | $ | 7.4 | | | $ | 3.3 | |
|
| Schedule of Stock-based Compensation Expense by Function |
The following table summarizes the total stock-based compensation expense by function and by type of award for the fiscal years ended March 31, 2026, 2025, and 2024 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Fiscal Year ended | | | March 31, | | | 2026 | | 2025 | | 2024 | | General and administrative | | $ | 13,177 | | | $11,505 | | $11,754 | | Advertising and marketing | | $ | 1,174 | | | 1,230 | | 1,177 | | Total stock-based compensation expense | | $ | 14,351 | | | $12,735 | | $12,931 | | | | | | | | | Stock-based compensation expense by type of award | | | | | | | | RSUs | | $ | 10,961 | | | $ | 9,856 | | | $ | 8,268 | | | Stock options | | 963 | | | 1,809 | | | 3,803 | | | Management Incentive Program | | 2,242 | | | 826 | | | 284 | | | Market-based award | | — | | | — | | | 304 | | | ESPP | | 185 | | | 244 | | | 272 | | | Total stock-based compensation expense | | $ | 14,351 | | | $ | 12,735 | | | $ | 12,931 | |
|